Temozolomide-Resistant Glioma Cells Are Sensitive to Chloroethylating Nitrosourea Compounds in Combination with ATR Inhibitors

被引：0
|
作者：
Jackson, C. [1 ]
Kalathil, A. N. [1 ]
Sundaram, R. K. [2 ]
Bindra, R. S. [1 ]
机构：
[1] Yale Univ, New Haven, CT USA
[2] Yale Univ, Sch Med, New Haven, CT USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2019.06.1098
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3481
引用
收藏
页码：E639 / E639
页数：1
相关论文
共 50 条
  • [41] Combination of a STAT3 Inhibitor and an mTOR Inhibitor Against a Temozolomide-resistant Glioblastoma Cell Line
    Miyata, Haruo
    Ashizawa, Tadashi
    Iizuka, Akira
    Kondou, Ryota
    Nonomura, Chizu
    Sugino, Takashi
    Urakami, Kenichi
    Asai, Akira
    Hayashi, Nakamasa
    Mitsuya, Koichi
    Nakasu, Yoko
    Yamaguchi, Ken
    Akiyama, Yasuto
    CANCER GENOMICS & PROTEOMICS, 2017, 14 (01) : 83 - 91
  • [42] EFFECT OF IFN-β AND LEVETIRACETAM ON RESISTANT GLIOMA CELLS TO TEMOZOLOMIDE
    Abe, Tatsuya
    Momii, Yasutomo
    Watanabe, Junko
    Morisaki, Ikuko
    Natsume, Atsushi
    Wakabayashi, Toshihiko
    Fujiki, Minoru
    NEURO-ONCOLOGY, 2013, 15 : 37 - 37
  • [43] Inhibition of DNA repair for sensitizing resistant glioma cells to temozolomide
    Kanzawa, T
    Bedwell, J
    Kondo, Y
    Kondo, S
    Germano, IM
    JOURNAL OF NEUROSURGERY, 2003, 99 (06) : 1047 - 1052
  • [44] MGMT-TRANSDUCED γδ T CELLS FUNCTION IN THE PRESENCE OF TEMOZOLAMIDE AND SHOW ENHANCED CYTOTOXICITY AGAINST TEMOZOLOMIDE-RESISTANT HIGH GRADE GLIOMA CELL LINES: POTENTIAL STRATEGIES FOR COMBINATION OF CHEMOTHERAPY AND IMMUNOTHERAPY
    Lamb, L. S.
    Bowersock, J.
    Dasgupta, A.
    Gillespie, G. Y.
    Spencer, H. T.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S205 - S205
  • [45] OLAPARIB IN COMBINATION WITH INHIBITORS OF ATR/CHK1 PATHWAY LEADS TO INCREASED CELL DEATH IN OVARIAN CANCER CELLS SENSITIVE AND RESISTANT TO PARPI
    Biegala, L.
    Gajek, A.
    Marczak, A.
    Rogalska, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A375 - A376
  • [46] Chemosensitization of Temozolomide-Resistant Pediatric Diffuse Midline Glioma Using Potent Nanoencapsulated Forms of a N(3)-Propargyl Analogue
    Shargh, Vahid Heravi
    Luckett, Jeni
    Bouzinab, Kaouthar
    Paisey, Stephen
    Turyanska, Lyudmila
    Singleton, William G. B.
    Lowis, Stephen
    Gershkovich, Pavel
    Bradshaw, Tracey D.
    Stevens, Malcolm F. G.
    Bienemann, Alison
    Coyle, Beth
    ACS APPLIED MATERIALS & INTERFACES, 2021, 13 (30) : 35266 - 35280
  • [47] Temozolomide-Resistant Human T2 and T98G Glioblastoma Cells
    Pinevich A.A.
    Bode I.I.
    Vartanyan N.L.
    Kiseleva L.N.
    Kartashev A.V.
    Samoilovich M.P.
    Cell and Tissue Biology, 2022, 16 (4) : 339 - 351
  • [48] Metformin plus sorafenib highly impacts temozolomide-resistant glioblastoma stem-like cells
    Aldea, Mihaela D.
    Petrushev, Bobe
    Soritau, Olga
    Tomuleasa, Ciprian I.
    Berindan-Neagoe, Ioana
    Filip, Adriana G.
    Chereches, Gabriela
    Cenariu, Mihai
    Craciun, Lucian
    Tatomir, Corina
    Florian, Ioan-Stefan
    Crivii, Carmen B.
    Kacso, Gabriel
    JOURNAL OF BUON, 2014, 19 (02): : 502 - 511
  • [49] Modulation of Antioxidant Potential with Coenzyme Q10 Suppressed Invasion of Temozolomide-Resistant Rat Glioma In Vitro and In Vivo
    Buric, Sonja Stojkovic
    Podolski-Renic, Ana
    Dinic, Jelena
    Stankovic, Tijana
    Jovanovic, Mirna
    Hadzic, Stefan
    Ayuso, Jose M.
    Virumbrales-Munoz, Maria
    Fernandez, Luis J.
    Ochoa, Ignacio
    Perez-Garcia, Victor M.
    Pasic, Milica
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2019, 2019
  • [50] lncRNA TUG1 inhibits the cancer stem cell-like properties of temozolomide-resistant glioma cells by interacting with EZH2
    Cao, Yiqiang
    Chai, Wenying
    Wang, Yonggang
    Tang, Dang
    Shao, Dongchuan
    Song, Hai
    Long, Jiang
    MOLECULAR MEDICINE REPORTS, 2021, 24 (01)
12345